Dose optimization of 2D X-ray image acquisition protocols in image-guided radiotherapy

PURPOSE

In contemporary radiotherapy, patient positioning accuracy relies on kV imaging. This study aims at optimizing planar kV image acquisition protocols regarding patient dose without degrading image quality.

MATERIALS AND METHODS

An image quality test-object was placed in-between PMMA plates, suitably arranged to model head or pelvis. Constructed phantoms were imaged using default protocols, the resultant image quality was assessed and the corresponding radiation dose was measured. The process was repeated using numerous kV/mAs combinations to identify those acquisition settings providing images at lower dose than the default protocols but without deterioration in image quality. Default and dose-optimized protocols were then tested on an anthropomorphic phantom and on 51 patients during two successive treatment sessions. Image quality was independently assessed by two readers. Organ and effective doses were estimated using a Monte Carlo simulation software.

RESULTS

Low-contrast detectability exhibited a stronger dependence on kV/mAs settings, compared to high-contrast resolution. Dose-optimized protocols resulted in significant dose reductions (anteroposterior-head 48.0 %, lateral-head 30.0 %, anteroposterior-pelvis 28.4 %, lateral-pelvis 27.0 %) compared to the default ones, without compromising image quality. Optimized protocols decreased effective doses by 54 % and 29.6 % in head and pelvic acquisitions, respectively. Regarding image quality, anthropomorphic and patient images acquired using the dose-optimized protocols were subjectively evaluated equivalent to those obtained with the corresponding default settings, indicating that the proposed protocols may be routinely used.

CONCLUSIONS

Given the potentially large number of radiotherapy fractions and the pertinent image acquisitions, dose-optimized protocols could significantly reduce patient dose associated with planar imaging without compromising positioning accuracy.

Synovial Sarcoma of Cheek: A Rare Case Report with Review of Literature

Synovial sarcomas are a rare entity in the head and neck region. We present a rare case of a 50 year old female presenting with a painless mass over right cheek since one year which gradually increased in size since past two months. Imaging was done which revealed a mass lesion in soft tissue of right cheek deep to the masseter muscle with no obvious involvement of the adjacent part of maxilla and mandible. Local wide excision of tumor was done. Histopathological examination revealed a malignant mesenchymal tumour. Further the specimen was subjected to immunohistochemical marker studies and diagnosis of high grade spindle cell sarcoma possibly synovial sarcoma was given. Patient then received Image guided radiation therapy and along with platinum based chemotherapy. Patient tolerated the treatment well. Patient was followed up for one year after completion of treatment and no recurrence was observed.

The first patients treated with MR-CBCT soft-tissue matching in a MR-only prostate radiotherapy pathway

INTRODUCTION

Magnetic Resonance (MR)-only radiotherapy for prostate cancer has previously been reported using fiducial markers for on-treatment verification. MR-Cone Beam Computed Tomography (CBCT) soft-tissue matching does not require invasive fiducial markers and enables MR-only treatments to other pelvic cancers. This study evaluated the first clinical implementation of MR-only prostate radiotherapy using MR-CBCT soft-tissue matching.

METHODS

Twenty prostate patients were treated with MR-only radiotherapy using a synthetic (s)CT-optimised plan with MR-CBCT soft-tissue matching. Two MR sequences were acquired: small Field Of View (FOV) for target delineation and large FOV for organs at risk delineation, sCT generation and on-treatment verification. Patients also received a CT for validation. The prostate was independently contoured on the small FOV MR, copied to the registered CT and modified if there were MR-CT soft-tissue alignment differences (MR-CT volume). This was compared to the MR-only volume with a paired t-test. The treatment plan was recalculated on CT and the doses compared. Independent offline CT-CBCT matches for 5/20 fractions were performed by three therapeutic radiographers using the MR-only contours and compared to the online MR-CBCT matches using two one-sided paired t-tests for equivalence within ±1 mm.

RESULTS

The MR-only volumes were significantly smaller than MR-CT (p = 0.003), with a volume ratio 0.92 ± 0.02 (mean ± standard error). The sCT isocentre dose difference to CT was 0.2 ± 0.1%. MR-CBCT soft-tissue matching was equivalent to CT-CBCT (p < 0.001), with differences of 0.1 ± 0.2 mm (vertical), -0.1 ± 0.2 mm (longitudinal) and 0.0 ± 0.1 mm (lateral).

CONCLUSIONS

MR-only radiotherapy with soft-tissue matching has been successfully clinically implemented. It produced significantly smaller target volumes with high dosimetric and on-treatment matching accuracy.

IMPLICATIONS FOR PRACTICE

MR-only prostate radiotherapy can be safely delivered without using invasive fiducial markers. This enables MR-only radiotherapy to be extended to other pelvic cancers where fiducial markers cannot be used.

The first reported case of a patient with pancreatic cancer treated with cone beam computed tomography-guided stereotactic adaptive radiotherapy (CT-STAR)

BACKGROUND

Online adaptive stereotactic radiotherapy allows for improved target and organ at risk (OAR) delineation and inter-fraction motion management via daily adaptive planning. The use of adaptive SBRT for the treatment of pancreatic cancer (performed until now using only MRI or CT on rails-guided adaptive radiotherapy), has yielded promising outcomes. Herein we describe the first reported case of cone beam CT-guided stereotactic adaptive radiotherapy (CT-STAR) for the treatment of pancreatic cancer.

CASE PRESENTATION

A 61-year-old female with metastatic pancreatic cancer presented for durable palliation of a symptomatic primary pancreatic mass. She was prescribed 35 Gy/5 fractions utilizing CT-STAR. The patient was simulated utilizing an end-exhale CT with intravenous and oral bowel contrast. Both initial as well as daily adapted plans were created adhering to a strict isotoxicity approach in which coverage was sacrificed to meet critical luminal gastrointestinal OAR hard constraints. Kilovoltage cone beam CTs were acquired on each day of treatment and the radiation oncologist edited OAR contours to reflect the patient's anatomy-of-the-day. The initial and adapted plan were compared using dose volume histogram objectives, and the superior plan was delivered. Use of the initial treatment plan would have resulted in nine critical OAR hard constraint violations. The adapted plans achieved hard constraints in all five fractions for all four critical luminal gastrointestinal structures.

CONCLUSIONS

We report the successful treatment of a patient with pancreatic cancer treated with CT-STAR. Prior to this treatment, the delivery of ablative adaptive radiotherapy for pancreatic cancer was limited to clinics with MR-guided and CT-on-rails adaptive SBRT technology and workflows. CT-STAR is a promising modality with which to deliver stereotactic adaptive radiotherapy for pancreatic cancer.

Simulated computed tomography-guided stereotactic adaptive radiotherapy (CT-STAR) for the treatment of locally advanced pancreatic cancer

BACKGROUND AND PURPOSE

We conducted a prospective, in silico imaging clinical trial to evaluate the feasibility and potential dosimetric benefits of computed tomography-guided stereotactic adaptive radiotherapy (CT-STAR) for the treatment of locally advanced pancreatic cancer (LAPC).

MATERIALS AND METHODS

Eight patients with LAPC received five additional CBCTs on the ETHOS system before or after their standard of care radiotherapy treatment. Initial plans were created based on their initial simulation anatomy (P_I) and emulated adaptive plans were created based on their anatomy-of-the-day (P_A). The prescription was 50 Gy/5 fractions. Plans were created under a strict isotoxicity approach, in which organ-at-risk (OAR) constraints were prioritized over planning target volume coverage. The P_I was evaluated on the patient's anatomy-of-the-day, compared to the daily P_A, and the superior plan was selected. Feasibility was defined as successful completion of the workflow in compliance with strict OAR constraints in ≥80% of fractions.

RESULTS

CT-STAR was feasible in silico for LAPC and improved OAR and/or target dosimetry in 100% of fractions. Use of the P_I based on the patient's anatomy-of-the-day would have yielded a total of 94 OAR constraint violations and ≥1 hard constraint violation in 40/40 fractions. In contrast, 39/40 P_A met all OAR constraints. In one fraction, the P_A minimally exceeded the large bowel constraint, although dosimetrically improved compared to the P_I. Total workflow time per fraction was 36.28 minutes (27.57-55.86).

CONCLUSION

CT-STAR for the treatment of LAPC cancer proved feasible and was dosimetrically superior to non-adapted CT-stereotactic body radiotherapy.

An international survey of imaging practices in radiotherapy

Improvements in delivery of radiation dose to target tissues in radiotherapy have increased the need for better image quality and led to a higher frequency of imaging patients. Imaging for treatment planning extends to function and motion assessment and devices are incorporated into medical linear accelerators (linacs) so that regions of tissue can be imaged at time of treatment delivery to ensure dose distributions are delivered as accurately as possible. A survey of imaging in 97 radiotherapy centres in nine countries on six continents has been undertaken with an on-line questionnaire administered through the International Commission on Radiological Protection mentorship programme to provide a snapshot of imaging practices. Responses show that all centres use CT for planning treatments and many utilise additional information from magnetic resonance imaging and positron emission tomography scans. Most centres have kV cone beam CT attached to at least some linacs and use this for the majority of treatment fractions. The imaging options available declined with the human development index (HDI) of the country, and the frequency of imaging during treatment depended more on country than treatment site with countries having lower HDIs imaging less frequently. The country with the lowest HDI had few kV imaging facilities and relied on MV planar imaging intermittently during treatment. Imaging protocols supplied by vendors are used in most centres and under half adapt exposure conditions to individual patients. Recording of patient doses, a knowledge of which is important in optimisation of imaging protocols, was limited primarily to European countries.

Recommendations for planning and delivery of radical radiotherapy for localized urothelial carcinoma of the bladder

PURPOSE

Curative radio-chemotherapy is recognized as a standard treatment option for muscle-invasive bladder cancer (MIBC). Nevertheless, the technical aspects for MIBC radiotherapy are heterogeneous with a lack of practical recommendations.

METHODS AND MATERIALS

In 2018, a workshop identified the need for two cooperative groups to develop consistent, evidence-based guidelines for irradiation technique in the delivery of curative radiotherapy. Two radiation oncologists performed a review of the literature addressing several topics relative to radical bladder radiotherapy: planning computed tomography acquisition, target volume delineation, radiation schedules (total dose and fractionation) and dose delivery (including radiotherapy techniques, image-guided radiotherapy (IGRT) and adaptive treatment modalities). Searches for original and review articles in the PubMed and Google Scholar databases were conducted from January 1990 until March 2020. During a meeting conducted in October 2020, results on 32 topics were presented and discussed with a working group involving 15 radiation oncologists, 3 urologists and one medical oncologist. We applied the American Urological Association guideline development's method to define a consensus strategy.

RESULTS

A consensus was obtained for all 34 except 4 items. The group did not obtain an agreement on CT enhancement added value for planning, PTV margins definition for empty bladder and full bladder protocols, and for pelvic lymph-nodes irradiation. High quality evidence was shown in 6 items; 8 items were considered as low quality of evidence.

CONCLUSION

The current recommendations propose a homogenized modality of treatment both for routine clinical practice and for future clinical trials, following the best evidence to date, analyzed with a robust methodology. The XXX group formulates practical guidelines for the implementation of innovative techniques such as adaptive radiotherapy.

Cone beam computed tomography for dose calculation quality assurance for magnetic resonance-only radiotherapy

•

Clinical Magnetic Resonance (MR)-only radiotherapy requires a dose quality assurance method.

•

Doses calculated on Cone Beam Computed Tomography (CBCT) were within 2% of MR-only doses calculated using synthetic CT.

•

CBCT with asymmetric dose difference tolerances of [−2%,1%] appears clinically feasible for quality assurance of prostate MR-only radiotherapy.

Background and purpose

Magnetic Resonance (MR)-only prostate radiotherapy using synthetic Computed Tomography (sCT) algorithms with high dose accuracy has been clinically implemented. MR images can suffer from geometric distortions so Quality Assurance (QA) using an independent, geometrically accurate, image could be required. The first-fraction Cone Beam CT (CBCT) has demonstrated potential but has not been evaluated in a clinical MR-only pathway. This study evaluated the clinical use of CBCT for dose accuracy QA of MR-only radiotherapy.

Materials and methods

A total of 49 patients treated with MR-only prostate radiotherapy were divided into two cohorts. Cohort 1 (20 patients) received a back-up CT, whilst Cohort 2 (29 patients) did not. All patients were planned using the sCT and received daily CBCT imaging with MR-CBCT soft-tissue matching. Each CBCT was calibrated using a patient-specific stepwise Hounsfield Units-to-mass density curve. The treatment plan was recalculated on the first-fraction CBCT using the clinically applied soft-tissue match and the doses compared. For Cohort 1 the sCT was rigidly registered to the back-up CT, the plan recalculated and doses compared.

Results

Mean sCT-CBCT dose difference across both cohorts was -0.6±0.1% (standard error of the mean, range −2.3%,2.3%), with 47/49 patients within [-2%,1%]. The sCT-CBCT dose difference was systematically lower than the sCT-CT by -0.7±0.6% (±95% limits of agreement). The mean sCT-CBCT gamma pass rate (2%/2mm) was 96.1±0.4% (85.4%,99.7%).

Conclusions

CBCT-based dose accuracy QA for MR-only radiotherapy appears clinically feasible. There was a small systematic sCT-CBCT dose difference implying asymmetric tolerances of [-2%,1%] would be appropriate.

A review of Image Guided Radiation Therapy in head and neck cancer from 2009-201 - Best Practice Recommendations for RTTs in the Clinic

Radiation therapy (RT) is beneficial in Head and Neck Cancer (HNC) in both the definitive and adjuvant setting. Highly complex and conformal planning techniques are becoming standard practice in delivering increased doses in HNC. A sharp falloff in dose outside the high dose area is characteristic of highly complex techniques and geometric uncertainties must be minimised to prevent under dosage of the target volume and possible over dosage of surrounding critical structures. CTV-PTV margins are employed to account for geometric uncertainties such as set up errors and both interfraction and intrafraction motion. Robust immobilisation and Image Guided Radiation Therapy (IGRT) is also essential in this group of patients to minimise discrepancies in patient position during the treatment course. IGRT has evolved with increased 2-Dimensional (2D) and 3-Dimensional (3D) IGRT modalities available for geometric verification. 2D and 3D IGRT modalities are both beneficial in geometric verification while 3D imaging is a valuable tool in assessing volumetric changes that may have dosimetric consequences for this group of patients. IGRT if executed effectively and efficiently provides clinicians with confidence to reduce CTV-PTV margins thus limiting treatment related toxicities in patients. Accumulated exposure dose from IGRT vary considerably and may be incorporated into the treatment plan to avoid excess dose. However, there are considerable variations in the application of IGRT in RT practice. This paper aims to summarise the advances in IGRT in HNC treatment and provide clinics with recommendations for an IGRT strategy for HNC in the clinic.

The accuracy of Magnetic Resonance - Cone Beam Computed Tomography soft-tissue matching for prostate radiotherapy

BACKGROUND AND PURPOSE

Magnetic Resonance (MR)-Only radiotherapy requires a method for matching image with on-treatment Cone Beam Computed Tomography (CBCT). This study aimed to investigate the accuracy of MR-CBCT soft-tissue matching for prostate MR-only radiotherapy.

MATERIALS AND METHODS

Three patient cohorts were used, with all patients receiving MR and CT scans. For the first cohort (10 patients) the first fraction CBCT was automatically rigidly registered to the CT and MR scans and the MR-CT registration predicted using the MR-CBCT and CT-CBCT registrations. This was compared to the automatic MR-CT registration. For the second and third cohorts (five patients each) the first fraction CBCT was independently matched to the CT and MR by four radiographers, the MR-CBCT and CT-CBCT matches compared and the inter-observer variability assessed. The second cohort used a CT-based structure set and the third a MR-based structure set with the MR relabelled as a 'CT'.

RESULTS

The mean difference between predicted and actual MR-CT registrations was Δ R All = - 0.1 ± 0.2 mm (s.e.m.). Radiographer MR-CBCT registrations were not significantly different to CT-CBCT, with mean differences in soft-tissue match ⩽ 0.2 mm and all except one difference ⩽ 3.3 mm . This was less than the MR-CBCT inter-observer limits of agreement [ 3.5 , 2.4 , 0.9 ] mm (vertical, longitudinal, lateral), which were similar ( ⩽ 0.5 mm ) to CT-CBCT.

CONCLUSIONS

MR-CBCT soft-tissue matching is not significantly different to CT-CBCT. Relabelling the MR as a 'CT' does not appear to change the automatic registration. This suggests that MR-CBCT soft-tissue matching is feasible and accurate.

Safety and efficacy of fiducial marker implantation for robotic stereotactic body radiation therapy with fiducial tracking

Purpose

The purpose of this study was to assess the feasibility, efficacy and toxicity of fiducial marker implantation and tracking in CyberKnife® stereotactic radiation therapy (SBRT) applied to extracranial locations.

Materials and method

This is a retrospective, single-centre, observational study to collect the data of all patients treated by stereotactic radiation therapy with fiducial marker tracking at extracranial locations, conducted between June 2014 and November 2017. Information regarding the implantation procedure, the types of toxicity related to marker implantation and the number of markers implanted/tracked during treatment were collected. Complication rates were evaluated using the CTCAE v4 [Common Terminology Criteria for Adverse Events] scale. The technical success rate was based on the ability to optimally track the tumor throughout all treatment fractions.

Results

Out of 2505 patients treated by stereotactic radiation therapy, 25% received treatment with fiducial marker tracking. The total number of implantation procedures was 616 and 1543 fiducial markers were implanted. The implantation-related complication rate was 3%, with 16 Grade 1 events and 4 Grade 2 events. The number of treated patients and the number of implanted markers has gradually increased since the technique was first implemented. The median treatment time was 27 min (range 10–76). 1295 fiducials were effectively tracked throughout all treatment fractions, corresponding to a technical success rate of 84%. The difference between the number of fiducials implanted and those tracked during treatment decreased significantly as the site’s experience increased.

Conclusion

Fiducial marker implantation and tracking is feasible, well-tolerated, and technically effective technique in SBRT for extracranial tumors.

[Modalities and advantages of image guided radiation therapy of breast cancer in adjuvant setting]

In adjuvant setting, breast cancer radiotherapy volumes include whole mammary gland or chest wall, and when indicated, nodal area such as axilla, supraclavicular, and internal mammary chain. An accurate patients positioning is required due to some geometric complexity of target volumes closed to organs at risk as heart and lung. Image guided radiation therapy allows such accuracy. Here we propose a review on image guided radiotherapy for breast cancer.

Early Outcome of Prostate Intensity Modulated Radiation Therapy (IMRT) Incorporating a Simultaneous Intra-Prostatic MRI Directed Boost

This study assessed the feasibility and outcomes of treating prostate cancer with intensity modulated radiotherapy (IMRT) incorporating a Magnetic Resonance Imaging (MRI) directed boost. Seventy-eight men received IMRT for localized prostate cancer. The entire prostate received 77.4Gy in 43 fractions and simultaneous intra-prostatic boosts (SIB) of 83Gy were administered to increase the dose to the MRI identified malignancy. In 16 (21%) patients, the MRI didn't detect a neoplasm and these patients received an SIB of 81Gy to the posterior prostate. Androgen Deprivation Therapy (ADT) was also administered to 32 (41%) patients. The 3-year rates of biochemical control, local control, distant control, and survival were 92%, 98%, 95%, and 95% respectively. While grade 1-2 toxicities were common, there were only 2 patients who suffered grade 3 toxicity. These patients developed strictures which were dilated resulting in improvement in symptoms such that both had grade 1-2 toxicity at last follow up examination. The results of this program of IMRT incorporating a MRI directed intra-prostatic boost suggest this technique is feasible and well tolerated. This technique appears to shift the therapeutic index favorably by boosting the malignancy to the highest dose without increasing the doses administered to the bladder and rectum.

Sci-Fri PM: Delivery - 10: Megavoltage x-ray imaging detector based on cerenkov effect

A Monte Carlo simulation was used to study imaging and dosimetric characteristics of a novel design of a megavoltage (MV) x-ray imaging detector. The proposed detector consists of a matrix of optical fibers aligned with the incident x-rays and coupled to an active matrix flat-panel imager (AMFPI) for image readout. The new design relies on Cerenkov effect for MV x-ray imaging and is named CPID (for Cerenkov Portal Imaging Device). When MV x-rays are incident on CPID, they interact within the volume of the detector primarily via Compton effect and pair-production, resulting in electrons and positrons. From these charged particles, those with sufficient energy, trigger production of optical light via Cerenkov effect. The light that is generated in the optical fibre cores within the acceptance angle of the fibers is guided towards the AMFPI. Properties, such as detection efficiency, modulation transfer function, zero frequency detective quantum efficiency (DQE), and energy response of the detector, have been investigated. It has been shown that the proposed detector can have a zero-frequency DQE more than an order of magnitude higher than that of current electronic portal imaging device (EPID) systems and yet a spatial resolution comparable to that of video-based EPIDs. In additional the proposed detector is less sensitive to scattered x-rays than current EPIDs.

Sci-Thur PM: YIS - 08: The effect of copper conversion plates on low-Z target image quality

Current generation electronic portal imaging devices (EPID) contain a 1.0 mm copper conversion plate to increase detection efficiency of a therapeutic megavoltage spectrum. When using these EPIDs for low-Z target imaging, the conversion plate largely attenuates the large populations of diagnostic energy photons, thereby decreasing the benefits of low-Z target imaging. In this work we measure directly the effect the variation in thickness of a copper conversion plate has on image quality in planar and cone beam computed tomography imaging. Monte Carlo modeling was used to quantify changes to the diagnostic spectrum and detector response for low-Z target beams generated with 2.35 and 7.00 MeV electrons incident on a carbon target. Planar contrast-to-noise ratio (CNR) measurements were made as a function of copper thickness. Cone beam computed tomography (CBCT) image CNR measurements were made as a function of dose both with and without the copper plate present in the EPID. The presence of copper in the EPID decreased the diagnostic photon population by up to 20% and suppressed the peak detector response at 60 kV by a factor of 6.4. Planar CNR was increased by a factor ranging from 1.4 to 4.0 with no copper present compared to 1.0 mm thickness. Increases in CBCT image CNR ranged from a factor of 1.3 to 2.1 with the copper plate removed. As a result of this we suggest that the copper conversion plate be removed from the EPID when used for low-Z target planar or CBCT imaging.

Poster - Thur Eve - 25: In vivo dosimetric verification of intensity-modulated radiation therapy

Dosimetric verification of patient treatment plans has become increasingly important due to the widespread use of complicated delivery techniques. IMRT and VMAT treatments are typically verified prior to start of the patient's course of treatment, using a point dose and/or a film measurement. Pre-treatment verification will not detect patient or machine-related errors; therefore, in vivo dosimetric verification is the only way to determine if the patient's treatment was delivered correctly. Portal images were acquired throughout the course of five prostate and six head-and-neck patient IMRT treatments. The corresponding predicted images were calculated using a previously developed portal dose image prediction algorithm, which combines a versatile fluence model with a patient scatter and EPID dose prediction model. The prostate patient image agreement was found to vary day-to-day due to rectal gas pockets and the effect of adjustable support rails on the patient couch. The head-and-neck patient images were observed to be more consistent daily, but an increased measured dose was evident at the periphery of the patient, likely due to patient weight loss. The majority of the fields agreed within 3% and 3 mm for greater than 90% of the pixels, as established by the χ-comparison. This work demonstrates the changes in patient anatomy that are detectable with the portal dose image prediction model. Prior to clinical implementation, the effect of the couch must be incorporated into the model, the image acquisition must be automatically scheduled and routine EPID QA must be undertaken to ensure the collection of high-quality EPID images.

SU-E-J-39: Minimizing IGRT Imaging Exposures: KV Radiograph Vs. KV-CBCT Vs. MV Portal Images

PURPOSE

To compare the IGRT doses from MV, kV and CBCT images.

METHODS

kV imaging systems integrated into Varian Trilogy and TrueBeam accelerators were modeled using BEAMnrc/DOSXYZnrc Monte Carlo codes and the dose to calibration phantoms for a variety of kV beams(kVp, bow-tie filters, etc.) were calculated. The doses to the same phantoms and kV beams were then measured experimentally using calibrated ion-chambers.The "calibrated" Monte Carlo kV beams were used to calculate dose to CT images of patients. Organ doses were analyzed using DVHs.

RESULTS

The doses to the prostate are 0.015 and 2.2cGy using AP kV and MV images; are 0.06 and 2.3cGy using lateral kV and MV images; and, are 1.7 cGy using CBCT images. For head and neck images, the doses to the eye are 0.08 and 0.001 cGy using AP and PA kV images; are 2.3 and 1.8cGy using AP and PA MV images; are 0.001 and 2.4cGy for lateral kV and MV images; and, are 0.2 cGy for CBCT images. For kV radiographs, organ doses can be further reduced, by over 30%, by using bow-tie filters. CBCT doses to the prostate are 1.6 and 0.9cGy for OBI and TrueBeam pelvis scans; a >40% dose reduction for the same image quality. For OBI CBCT head scans the doses to the eye and brain stem are 0.2 and 2.8cGy, respectively.

CONCLUSIONS

Due to the low penetration of kV beams,selecting beam angles so that the sensitive organs are near the beam exit, and/or using bow-tie filters, can substantially reduce organ doses when using kV radiographs. For daily positioning of pediatric brain patient with a set of orthogonal kV images, a CBCT scan, or a set of orthogonal MV images, the doses to the eyes are 0.1, 0.2, and 4.7 cGy, respectively.

SU-E-J-21: An Intercomparison of Imaging Performance of Two Linac-Mounted Imaging Systems Used in Radiation Therapy: TrueBeam and Trilogy

PURPOSE

To evaluate and compare the performance of the imaging systems of two linear accelerators, used in radiation therapy. The study includes the following imaging components: electronic portal imaging device (EPID), kilovoltage projection imaging and kilovoltage cone-beam CT.

METHOD AND MATERIALS

The imaging systems mounted on the Varian Trilogy (Varian Medical Systems) and Varian TrueBeam, were evaluated. Image quality of two EPID systems (ASI-1000) and the two kV flat panel imagers (PaxScan 4030CB) was evaluated in terms of spatial resolution and contrast-to-noise ratio (CNR) using the QC-3 and QCkV-1 phantoms (Standard Imaging, Inc.). Cone-beam CT image sets of the CatPhan phantom (The Phantom Lab.) were obtained for standard dose head (100kVp, 0.4mAs per projection) and body (125kVp, 1.04mAs) protocols. Imaging parameters of the default clinical settings were used. The end points of the comparison were spatial resolution, CT number linearity, low contrast detectability and image uniformity. Analysis of all types of images was performed by the PIPSpro software (Standard Imaging).

RESULTS

The critical frequency (f50 in units of lp/mm) of 0.446 and 0.403 were obtained for TrueBeam and Trilogy MV detectors, respectively. The CNR was found double for Trilogy. For kilo-voltage detectors the f50 was 1.337 and 1.363, while the CNR was better by 6% in Trilogy machine. The CBCT comparison showed a 30% higher uniformity index for the TrueBeam system for pelvis protocol and 50% higher head. No significant difference was found in low contrast detectability and CT number linearity and resolution, 5 lp/mm. The Trilogy image was noisier by 35% and 30% for pelvis and standard head protocol, respectively.

CONCLUSIONS

The critical frequencies of both kV and MV detectors were found better in TrueBeam, while CNRs were found better in Trilogy. TrueBeam preformed superiorly in CBCT in terms of image uniformity and noise level.

TU-E-BRB-06: Best in Physics (Therapy) - Development and Experimental Validation of EPID-Based 4D Dose Reconstruction

PURPOSE

To develop and validate an EPID-based 4D patient dose reconstruction framework accounting for linac delivery uncertainties, interfractional and intrafractional motions, and interplay effect.

METHODS

Patients with fiducial markers were scanned with 4D-CT for SBRT planning. Before treatment, in-room 4D-CT was performed. Both the MLC and the tumor movements were tracked by continuously acquiring EPID images during treatment. Instead of directly using the heterogeneous transit photon fluence measured by the EPID, this method reconstructed the incident beam fluence based on the MLC apertures measured by the EPID and the delivered MU recorded by the linac. To account for the time-dependent-geometry, the incident fluence distributions were sorted into their corresponding phases based on the tumor motion pattern detected by the EPID and accumulated as the incident fluence map for each phase. Together with 4D-CT, it was then used for Monte Carlo dose calculation. Deformable registration was performed to sum up the phase doses for treatment assessment. The feasibility of using the transit EPID images for incident fluence reconstruction was evaluated against EPID in-air measurements. The accuracy of 3D- and 4D-dose reconstruction was validated by a motordriven cylindrical diode array for six clinical SBRT plans.

RESULTS

The average difference between the measured and reconstructed fluence maps is within 0.16%. The reconstructed 3D-dose shows 1.4% agreement in the CAX-dose and >98.5% gamma-passing-rate (2%/2mm) in the peripheral-dose. A distorted dose distribution is observed in the measurement for the moving ArcCheck-phantom. The comparison between the measured and the reconstructed 4D-dose without considering interplay fails the gammaevaluation (59%-88.9% gamma-passing-rate). In contrast, when the interplay is considered, the dose distortion phenomena is successfully represented in the reconstructed dose (>97.6% gamma-passing-rate).

CONCLUSIONS

The experimental validation demonstrates that the proposed method provides a practical way to reconstruct the fractional 4D-doses received by the patient and enables adaptive SBRT strategy.

WE-G-BRB-02: MU-EPID an EPID Based Tool for IMRT Quality Assurance

PURPOSE

A software program (MU-EPID) has been developed to perform patient specific IMRT pre-treatment QA verification using an electronic portal imaging device.

METHODS

The software converts measured images of intensity modulated beams delivered to an EPID, into fluence maps that can be imported in the treatment planning system. The dose can then be calculated in the patient anatomy and compared against the patient's treatment plan for QA purposes. We first benchmarked the software using as a patient a cylindrical phantom. An aSi-1000 EPID mounted on a Varian Novalis linear accelerator was used for the image acquisition. Finally, IMRT plans from different treatment sites were used to further validate this in- house software. QA analysis was performed by evaluation of isodose distributions, DVH comparison and 2D gamma analysis.

RESULTS

The validation study with the cylindrical phantom showed that the dose to the ion chamber measurement point was in good agreement with both the original treatment plan and the MU-EPID reconstructed dose. Similar results were found for the clinical cases that we studied. A gamma analysis of the dose to the isocenter plane was performed for each plan. Using 3% and 3 mm as the evaluation criteria, resulted in an average of 97.44% of pixels passing the analysis (gamma<1). Good agreement was also observed for the DVH, isodose and profile comparisons between the clinically delivered IMRT plan and the MU-EPID derived dose calculation.

CONCLUSIONS

The results of the present investigation suggest that MU-EPID can be used in a clinical environment and can be used for patient specific QA for IMRT plans. This work has been supported by the SCOA.

TU-E-BRA-01: A Comparison of Various Online Strategies to Account for Interfractional Variations for Pancreatic Cancer

PURPOSE

To indentify effective methods to address the large interfractional variations for pancreas irradiation, we compared various used/proposed online strategies.

METHODS

The daily CTs acquired using a respiration-gated in-room CT for 9 pancreatic cancer patients treated with IGRT (i.e., online repositioning based on rigid-body alignment) were analyzed. The contours of the pancreas and duodenum on each daily CT set were generated by populating those from the planning CT using a deformable registration tool (ABAS, Elekta) with manual editing. PTV was generated with 3 mm margin. Nine online strategies were considered: 1) IGRT with 0 mm additional margin (AM), 2) IGRT with 2mm AM, 3) IGRT with 5mm AM, 4) IGRT with plan renormalized to maintain 95% PTV coverage, 5) Full scale reoptimization, 6) Reoptimization starting from the original plan, 7) Segment Aperture Morphing (SAM) from the original plan based on PTV shape change 8) SAM plus Segment Weight Optimization (SWO), 9) Reoptimization starting from the SAM plan. One way ANOVA (analysis of variance) was applied to plan qualities for the 9 strategies to assess statistical significance in difference.

RESULTS

The standard IGRT strategies (1-3) resulted in either inadequate PTV coverage or higher duodenum doses. Margin expansion along is not efficient to account for the changes. Full-scale reoptimization resulted in the best plan but requiring delineation of several structures. Reoptimization on top of available plan (strategies 6 and 9) was considerably faster. SAM strategy (7) is the fastest online replanning, as it requires only one structure (target) delineation, and it's plan quality was comparable to that for the full-scale reoptimization.

CONCLUSION

Online replanning strategies can lead to either reduced duodenum dose or improved target coverage as compared to the current practice of IGRT. The SAM-based online replanning is comparable to the full scale reoptimization and is efficient for practical use.

WE-E-213AB-01: Medical Physics Challenges for Implementation of New Technologies in External Beam Radiotherapy

The AAPM has signed two formal Educational Exchange Agreements with the Spanish (SEFM) and the Russian (AMPR) medical physics societies. While the primary purpose of the Agreements is to provide educational opportunities for young medical physicists, the Agreements also contemplate holding joint sessions at scientific congresses. The purpose of this professional AAPM/SEFM/AMPR Joint Symposium is to explore the challenges that medical physicists in the three countries face when new external beam radiotherapy technologies are introduced in their facilities and to suggest potential solutions to limitations in testing equipment and lack of familiarity with protocols. Speakers from the three societies will present reviews of the technical aspects of IMRT, Arc EVIRT (IMAT/VMAT/Rapid Arc), SRS/SRBT, and IGRT/Adaptive radiotherapy, and will describe the status of these technologies in their countries, including the challenges found in tasks such as developing anatomical and biological dose optimization techniques and implementing QA management, risk assessment and patient safety programs. The SEFM will offer AAPM and AMPR members the possibility to participate in collaborative proposals for future research bids in UE and USA based on an ongoing Spanish project for adaptive radiotherapy using functional imaging. A targeted discussion will debate three propositions: the cost/benefit ratio of IGRT, whether IMRT requires IGRT, and the use of non-ionizing radiation technologies for realtime monitoring of prostate IGRT. For these debates, each society has designated one speaker to present and defend either "For" or "Against" the proposition, followed by discussion by all participants. The Symposium presentations and the country-tailored recommendations drawn will be made available to each society for inclusion in their websites. The WGNIMP, the AAPM Work Group charged with executing the AAPM/SEFM and AAPM/AMPR Agreements, will follow up on the commitments made by the AAPM.Di Yan's research on adaptive radiotherapy has been financially supported by: 1) NIH Research Grants, 2) Elekta Research Grants 3) Philips Research GrantConflicts of interest for Cedric X Yu: 1) Board Member of Prowess, Inc., 2) Shareholder of Xcision Medical Systems, LLC, 3) Inventor on patents licensed by Varian Medical Systems, Inc.

LEARNING OBJECTIVES

1. Describe fundamental aspects for four advanced radiotherapy techniques: IMRT, IGRT, SBRT, and adaptive radiotherapy. 2. Review technical and professional challenges for implementation of advanced techniques as a function of resources and capabilities available within each scientific society: AAPM, SEFM, and AMPR. 3. Discuss and plan a proposal for an international trial on IMRT/IGRT based on functional imaging. 4. Debate important implementation aspects of IMRT and IGRT according to country-specific resources.

SU-D-BRA-03: Simultaneous MV-KV Imaging for Intra-Fractional Motion Management during Volume Modulated Arc Therapy (VMAT) Delivery on the Varian TrueBeam

PURPOSE

To evaluate a MV-kV intra-fractional imaging technique for use during volume modulated arc therapy (VMAT) with the Varian TrueBeam.

METHODS

MV-kV image pairs were acquired intra-fractionally during VMAT delivery. kV images (11 fps) were acquired throughout delivery using a standard pre-programmed imaging template. MV images (9.5 fps) were acquired simultaneously by deploying the EPID and passively collecting the resulting images using Varian proprietary software, iTools Capture. Localization accuracy was evaluated by imaging a Rando phantom implanted with 3 fiducials while moving the couch according to XML- programmed trajectories simulating typical prostate and respiratory motion. VMAT delivery was done using a single 360 degree arc in TrueBeam Developer mode. The effect on accuracy of total MU and gantry speed was studied. To improve image quality, MV frame averaging was performed and the MV and kV images were then registered to their corresponding DRRs using in-house registration software. From these 2D registrations, the 3D position at each MV-kV acquisition point was determined.

RESULTS

Between 130 and 390 MV-kV pairs were acquired for each delivery. The mean difference between planned couch and measured fiducial 3D positions with prostate motion was less than 0.03 cm in each direction (SD 0.03 cm). Neither gantry speed nor MU significantly impacted accuracy. for respiratory motion, the mean difference between planned and measured position was less than 0.04 cm. Standard deviation averaged 0.06 cm but increased to 0.12 cm with large instantaneous motion and less MV dose per frame. MV frame averaging and inaccuracies in MV image gantry angle determination also affected accuracy, particularly with significant motion.

CONCLUSIONS

With high quality MV imaging, MV-kV localization techniques can be highly accurate, even in the presence of significant motion. As clinical MV-kV methods become available, such techniques can provide an efficient and accurate method for monitoring intra-fractional motion. This work was partially supported through a research agreement with Varian Medical Systems, Palo Alto, CA.

SU-E-J-14: Evaluation of Mechanical Accuracy of Electronic Portal Imaging Devise on Its Use in Patient Specific IMRT QA

PURPOSE

Electronic portal imaging devices (EPID) have been used for both in vivo dosimetry and in vitro dose verification in intensity modulated radiotherapy (IMRT). This study is to investigate the effect of EPID mechanical precision on the accuracy of measured dose distribution.

METHODS

EPID energy fluences (dicom images) of H&N IMRT fields were collected daily on two Varian LINACs (Clinac-iX & Trilogy) over 4-week period. The energy fluences were converted to doses using EPIDoseTM (Sun Nuclear Corp). Mechanical deviations of EPIDs could be divided into two components: one with inherent detector center misalignment from the beam central axis, another caused by the 'sagging effect' from gantry rotation. The first component was detected by 'best matching' of the measured and calculated dose at zero gantry angle (G=0). The second component was computed by 'best matching' the 10×10cm field defined by MLC at G=0, 90,180, and 270, separately. A 'shift' was generated by the combination of these two components and then applied to correct the measured dose at the corresponding gantry angle for the IMRT field.

RESULTS

Inherent misalignment of the detector's center and the 'sagging' deviation were found to be 1-2 mm and 1-5 mm, respectively for both LINACs. Each component was found very stable (change < 1mm) over the 4-week observational period. Using a Gamma index of 2%/2mm (DD/DTA), the 'shift' increased the average passing rate from 59% to more than 92%. On the other hand, blindly applying 'auto-shift' from commercially available software to obtain the best match would compound true QA issues with units' misalignments.

CONCLUSIONS

A false 'mismatch' between measured and calculated dose distribution caused by mechanical inaccuracies of EPID could be avoided by measuring the two components identified in this study. One should examine the mechanical precision of equipment prior to clinical use of EPID dosimetry.

MO-F-BRA-05: Real-Time 3D Tumor Localization for Lung IGRT Using a Single X-Ray Projection

PURPOSE

To study the feasibility of a novel 2D/3D image registration method, called Projection Metric Learning for Shape Kernel Regression (PML-SKR), in supporting on-board x-ray imaging systems to perform real-time image-guided radiation therapy in the lung.

METHODS

PML-SKR works in two stages: planning and treatment. At planning stage, firstly it parameterizes the patient's respiratory deformation from the patient's treatment-planning Respiratory-Correlated CTs (RCCTs) by doing PCA analysis on the inter-phase respiratory deformations. Secondly, it simulates a set of training projection images from a set of deformed CTs where their associated deformation parameters are sampled within 3 standard deviations of the parameter's values observed in the RCCTs. Finally, it learns a Riemannian distance metric on projection intensity for each deformation parameter. The learned distance metric forms a Gaussian kernel of a kernel regression that minimizes the leave-one-out regression residual of the corresponding deformation parameter. At treatment stage, PML-SKR interpolates the patient's 3D deformation parameters from the parameter's values in the training cases using the kernel regression with the learned distance metrics.

RESULTS

We tested PML-SKR on the NST (Nanotube Stationary Tomosynthesis) x-ray imaging system. In each test case, a DRR (dimension: 64×64) of an x-ray source in the NST was simulated from a target CT for registration. The target CTs were deformed by normally distributed random samples of the first three deformation parameters. We generated 300 synthetic test cases from 3 lung datasets and measured the registration quality by the mTRE (mean Target Registration Error) over all cases and all voxels at tumor sites. With PML-SKR's registrations, the average mTRE and its standard deviation are down from 10.89±4.44 to 0.67±0.46 mm using 125 training projection images. The computation time for each registration is 12.71±0.70 ms.

CONCLUSION

The synthetic results have shown PML-SKR's promise in supporting real-time, accurate, and low-dose lung IGRT. This work was partially supported by Siemens Medical Solutions.

TU-E-BRA-03: Real-Time Fiducial Detection and Prostate Movement Assessment with Cine MV Images in RapidArc Treatments

PURPOSE

To develop an algorithm for detection of metallic fiducial markers in cine MV images, and to assess the prostate movement during RapidArc treatment.

METHODS

A Varian TrueBeam linear accelerator (LINAC) was used to deliver RapidArc treatment for prostate patients. Cine images were acquired with the onboard electronic portal imaging device (EPID) using the MV therapeutic beam. Three metallic fiducial markers were implanted inside the prostate. To detect the fiducial position, we explicitly account for the possible marker blockage by MLC during beam modulation. If the marker is not blocked, we employ the planning coordinates of the marker centroids projected onto the cine MV images and perform template matching in the vicinity of its projection to localize the actual position of the marker. Displacements of the fiducial markers are assessed by comparing the actual and planned positions.

RESULTS

We analyzed ∼280 cine MV images acquired during a 55-sec RapidArc treatment for a prostate patient. The three markers were visible in about 46%, 52%, and 48% of the images, and at least one fiducial was visible during almost entire treatment (97% of the time). The marker detection algorithm agrees well with manual detection (< 0.2 mm). The mean displacement for each fiducial was 0.40 ± 0.42, 0.27 ± 0.29, and 0.46 ± 0.34 mm. The maximum displacement was 2.33, 1.75, and 2.23 mm.

CONCLUSIONS

An algorithm for automatic detection of fiducial markers in cine MV images has been developed. The prostate movement during a RapidArc treatment has been analyzed for a patient with implanted markers. Accurate target positioning is achieved at all times during treatment. In light of the random nature of intrafraction prostate motion, this work represents an important step toward real-time image-guided prostate radiation therapy.

SU-E-J-139: Feasibility of Using EPID for Real-Time Target Localization during Treatment

PURPOSE

This study aims to investigate the feasibility of using the images of the treatment fields acquired by an electronic portal imaging device (EPID) for real-time target localization.

METHODS

Forty one patients treated with IMRT and RapidArc were recruited in this study including 37 prostate patients and 4 lung patients. These patients were grouped as: prostate IMRT with lymph node (n=14), prostate IMRT without lymph node (n=17), prostate RapidArc (n=6), and lung IMRT (n=4). For each patient, two to four fiducial markers were implanted inside the tumor. The DRR, which projects the patient anatomy and the fiducial marker at the EPID location, was reconstructed for each field. The MLC aperture of each control point was overlay on its corresponding DRR to evaluate the fractional time when the fiducial marker was seen on the EPID image. The probability of seeing at least one, two, three, and four fiducial markers during the treatment was recorded.

RESULTS

For the prostate IMRT patients without lymph nodes included in the target volume, the average probability of seeing at least one, two, three, and four fiducial markers during the treatment was 50% (35%-59%), 39% (23%-51%), 24% (7%-38%), and 12% (4%-29%), respectively. For the prostate IMRT patients with lymph nodes, the probability was 41% (24%-51%), 29% (12%-42%), 15% (3%-24%), and 7% (4%-15%), respectively. For prostate RapidArc treatments using two arcs, the average probability of seeing at least one fiducial marker was 81% (58%-90%) for the full arc and 74% (53%-94%) for the partial arc. For the lung IMRT treatment, the average probability of seeing at least one fiducial marker was 34% (20%-52%).

CONCLUSIONS

The continuous image acquisition from the EPID during the treatment provides sufficient target movement information for real-time target localization and intrafractional target motion correction for advanced radiotherapy treatments.

SU-E-J-64: Towards a Patient Specific Deformation Model in the Male Pelvis for IGRT via Limited Angle Imaging

PURPOSE

To evaluate the feasibility of patient specific deformation models (PSDM) in the male pelvis for IGRT by limited angular imaging.

METHODS

In IGRT via limited angular imaging, insufficient angular projections are acquired to uniquely determine a 3D attenuation distribution. For highly limited geometries, image quality may be too poor for successful non-rigid registration. This can be overcome by restricting the transformation space to one containing only feasible transformations learned from prior 3D images. This has been successfully applied in the lung region where a majority of deformation is due to respiratory motion which can be adequately observed at planning time with RCCT. Typically, the phases of the RCCT are registered together to form an group-wise mean image and transformations to each training image. PCA is then performed on the transformation displacement vector fields. The transformation is found at treatment time by registration of digitally reconstructed radiographs of the transformed image to the measured projections, optimizing over the parameters of the PCA subspace. In the male pelvis, deformation is much more complicated than respiratory deformation and is largely inter-fractional due to changes in bladder and rectal contents, articulation, and motion of the bowels. A similar model is developed for the male pelvis which takes into account pelvic anatomical information and handles the more complicated deformation space.

RESULTS

Using the leave-one-out method, dice similarity coefficients in the prostate compared with manual segmentations are increased over the those obtained by rigid registration and are comparable with those obtained by 3D non-rigid registration methods.

CONCLUSIONS

This method produces better results than rigid registration and is comparable with results obtained by 3D/3D registration even though it uses limited angle projections. However, its relies on daily training CTs, so it is not yet a viable clinical method. Funding provided in part by Siemens Medical.

SU-E-T-171: Missing Dose in Integrated EPID Images

PURPOSE

A dosimetric artifact has been observed with Varian EPIDs in the presence of beam interrupts. This work determines the root cause and significance of this artifact.

METHODS

Integrated mode EPID images were acquired both with and without a manual beam interrupt for rectangular, sliding gap IMRT fields. Simultaneously, the individual frames were captured on a separate computer using a frame-grabber system. Synchronization of the individual frames with the integrated images allowed the determination of precisely how the EPID behaved during regular operation as well as when a beam interrupt was triggered. The ability of the EPID to reliably monitor a treatment in the presence of beam interrupts was tested by comparing the difference between the interrupt and non-interrupt images.

RESULTS

The interrupted images acquired in integrated acquisition mode displayed unanticipated behaviour in the region of the image where the leaves were located when the beam interrupt was triggered. Differences greater than 5% were observed as a result of the interrupt in some cases, with the discrepancies occurring in a non-uniform manner across the imager. The differences measured were not repeatable from one measurement to another. Examination of the individual frames showed that the EPID was consistently losing a small amount of dose at the termination of every exposure. Inclusion of one additional frame in every image rectified the unexpected behaviour, reducing the differences to 1% or less.

CONCLUSIONS

Although integrated EPID images nominally capture the entire dose delivered during an exposure, a small amount of dose is consistently being lost at the end of every exposure. The amount of missing dose is random, depending on the exact beam termination time within a frame. Inclusion of an extra frame at the end of each exposure effectively rectifies the problem, making the EPID more suitable for clinical dosimetry applications. The authors received support from Varian Medical Systems in the form of software and equipment loans as well as technical support.

SU-E-T-579: Dosimetric Benefits of Online Adaptive Replanning for Post-Operative Radiation Therapy of Prostate Bed

PURPOSE

To demonstrate the dosimetric benefits of using an online adaptive replanning scheme to address interfractional variations in radiotherapy of prostate bed.

METHODS

We have previously developed an online adaptive replanning tool (RealART, Prowess Inc.) aiming to address interfractional variations including organ deformation and rotation. Using this tool, we analyzed a total of 102 daily pre-treatment CTs acquired using an in-room CT (CTVision, Siemens) for 10 patients treated with post-operative IMRT of prostate bed. The PTV was assumed to be the volume enclosed by the 95% prescription isodose surface generated for the conventional four field box. On each daily CT set, contours of the PTV, rectum and bladder were generated by populating the planning contours using an auto-segmentation tool based on deformable registration (ABAS, Elekta) with manual editing. Four plans were generated and compared: (1) IGRT (repositioning) plan by copying the original plan with aligning the anterior rectal wall from the daily CT to that of the planning CT, (2) IGRT plan by copying the original plan with aligning the surgical clips, (3) online adaptive plan by tailoring the original plan to conform to the anatomy of the day, and (4) a new plan re- optimized based on the daily anatomy.

RESULTS

The adaptive and re- optimization plans are in general superior than the two repositioning plans in terms of both target coverage and critical structure sparing. For example, the averages of dose volume quantities for all daily CTs are: rectum V45Gy 55.7±18.0% (one standard deviation), 57.3±17.5%, 48.2±11.8%, 42.5±9.6%; rectum V60Gy 31.8±20.3%, 34.0±16.6%, 22.6±9.7%, 16.5±7.4%; bladder V45Gy 30.0±11.9%, 39.5±24.2%, 37.6±16.8%, 36.5±16.2%; bladder V60Gy 17.4±9.2%, 25.4±18.1%, 24.7±12.7%, 23.9±12.0%; PTV V100 81.9±16.6%, 88.7±7.9%, 92.9±4.6%, and 94.6±2.4% for the above (1)-(4) plans, respectively.

CONCLUSIONS

The online adaptive replanning scheme is effective to account for interfractional variations in post-operative radiotherapy of prostate bed. This work is supported partially by MCW Cancer Center Fotsch Foundation.

SU-E-T-88: Evaluating Gantry Sag on Linear Accelerators and Introducing an MLC-Based Compensation Strategy

PURPOSE

Gantry sag is one of the well-known sources of mechanical imperfections that compromise the spatial accuracy of radiation dose delivery. This study aims to quantify the gantry sag on multiple linacs and to investigate a multiple leaf collimator (MLC)-base strategy to compensate for gantry sag.

METHODS

We used the Winston-Lutz method to measure the gantry sag on three Varian linacs. A ball-bearing phantom was imaged with a square radiation field during gantry rotation. The images were analyzed to derive the radiation isocenter and subsequently the gantry sag, that is, the superior-inferior wobble of the radiation field center from the radiation isocenter as a function of gantry angle. Compensation for gantry sag was attempted by offsetting the MLC leaves at 90-degree collimator angle. The amount of offset was the opposite of measured gantry sag, which was gantry angle-specific.

RESULTS

Gantry sag was reproducible within a six-month period. On the three linacs, the maximum gantry sag was found to vary from 0.7 mm to 1.0 mm, depending on the linac and the collimator angle. The radiation field center moved inferiorly, or away from the gantry, when the gantry was rotated from 0 to 180 degrees. Comparison of gantry sag at 0- and 90-degree collimator angles showed that the uncertainty in MLC leaf positions did not increase the gantry sag. Instead, gantry sag was caused primarily by nonideal gantry rotation. After the MLC compensation was applied, the maximum gantry sag was reduced to less than 0.2 mm.

CONCLUSIONS

The results indicated that gantry sag on a linac can be quantitatively measured with sub-millimeter precision, using a simple ball-bearing phantom and the electronic portal imaging device. Reduction of gantry sag is feasible by applying a gantry angle-specific correction to MLC leaf positions at 90 degree collimator angle.

TU-E-BRB-11: End-To-End Positioning Quality Assurance for Image-Guided Radiosurgery of Multiple Targets Using a Single-Isocenter

PURPOSE

Using a single isocenter significantly reduces delivery times in radiosurgery involving multiple targets. However, because not every target can be placed at isocenter with this type of treatment, a conventional Winston-Lutz test cannot be used. We describe a novel Winston-Lutz like mulitarget test (MTT) for verifying accurate positioning.

METHODS

A target phantom, comprised of an acrylic plate with recesses for three 3/4″ spheres was constructed and a high-resolution (0.5×0.5×0.8 mm) CT scan obtained with PTFE spheres placed in the recesses. The scan was imported into a commercial treatment planning system and multiple beams were prepared, having their isocenter at the centroid of the arrangement of spheres. Every beam incorporated three MLC-defined rectangular apertures that circumscribed the spheres. Custom software selected setup parameters (table, gantry and collimator angle, MLC openings) such that the spheres were centered as precisely as possible within their respective MLC fields, considering the discrete width of collimator leaves. The phantom, with the PTFE replaced by steel spheres, was placed on the treatment couch and imaged using stereoscopic x-ray beams. A 6 degree-of-freedom robotic couch applied translations and rotations to reproduce the CT position. A MV EPID rendered images of the spheres within their respective apertures, allowing identification of sphere and aperture centers. Any error upstream would manifest itself as inaccurate centering of a sphere.

RESULTS

Eight beams with table angle 0 and two beams each with table angles 49.7, 89.8, 272.3, and 310.1 were selected. The maximum calculated distance between any sphere and the respective aperture center was 0.07 mm. The median difference measured from the MV images ranged from 0.1 mm to 1.4 mm with a median of 0.8 mm.

CONCLUSIONS

The MTT is a practical end-to-end test for quality assurance of the entire positioning process in multitarget radiosurgery, from CT scanning to beam delivery.

SU-E-J-103: Characteristics of Bladder Wall Deformation as a Function of Bladder Filling

PURPOSE

ICRU report 83 recommends delineation of the wall for hollow organs such as the bladder. For image guided radiotherapy, there is no guidance as to how to delineate deformed walls as the filling of hollow organs change. This work investigates characteristics of bladder wall deformation as a function of bladder filling in a controlled process.

METHODS

CT images of a fresh pig bladder are obtained in-air with different bladder air fillings. A plastic hose inserted into and glued to the bladder neck forms an air-tight seal for filling with a syringe. At each air-filling level, a helical CT (90kV, 90mAs) of the bladder is obtained. The pixel size on all CT images is <0.5 mm. Images are imported into a commercial planning system for delineation and statistical evaluation. Bladder walls at each filling status are auto-contoured, then edited for quality assurance slice by slice. The auto-contouring threshold is selected to obtain consistent volumes of the resulting region-of-interest at each filling status.

RESULTS

When the bladder wall interior volume increases by 360 cm³ from injecting air, the wall thickness decreases from 2.9 mm to 1.2 mm. The decrease in wall thickness is accompanied by a decrease in the wall CT number.

CONCLUSIONS

For a pig bladder, the wall thickness decreases with increased air filling. The CT number (hence apparent density) of the volume decreases as the bladder expands. Further investigation is ongoing to determine if the apparent density decrease is real, due to CT reconstruction, or due to the bladder being in an air, rather than liquid environment. Characterization of hollow organ wall thickness variations may be important for image guided radiation therapy and organ wall dose evaluation. Support: P01CA116602.

SU-E-J-48: Real Time Image Guided Localization in SBRT Lung/Liver Patients Radiation Treatment

PURPOSE

Stereotactic body radiation therapy (SBRT) lung/liver patientradiation treatment requires high precision of patient position and target localization. For SBRT lung/liver patients positioning, cone beam CT imaging has been widely used, generally with zero couch rotation. The purpose of this study is to implement Stereotactic radiation surgery (SRS) patient positioning technology to SBRT by expanding patient positioning with couch rotation.

METHODS

A Varian® Novlis Tx for SRS treatment wasused to treat SBRT lung/liver patients implementing CBCT. BrainLAB® X-ray imaging system in conjunction with optical guidance is primarily used for SRS patients. CBCT and X-ray imaging system were independently calibrated with 1.0 mm accuracy. The X-ray imaging system was implemented through BrainLAB® ExacTrac system with CBCT localized position at the initial zero position for the X-ray imaging system. For the other couch positions, X-ray images were fused with patient DRRs for positioning.

RESULTS

Based on daily imaging QA records for a period oftwo years, the longitudinal, vertical and lateral coordination between CBCT and X-ray imaging average 0.3+/-0.5, 0.2+/-0.5 and 0.5+/-0.5 mm. The shiftfrom the CBCT imaging isocenter to the X-ray imaging isocenter is 0.5+/-0.5 mm accuracy for a 24-month period of tracking. Patient position accuracy: After initially localizing the patient with CBCT at the zero couch position, the patient was positioned with the X-ray imaging system. The computed translational and rotational shift accuracy are 0.5+/-0.5 mm and0.4+/-0.3 degree respectively, based on 66 SBRT lung/liver patients couchrotations.

CONCLUSIONS

Accurate coordination of CBCT and X-ray imaging in conjunction with optical imaging guidance can be expanded to patient positioning with couch rotation. The X-ray imaging capability at rotated-couch positions improved the physician confidence level during SBRT lung/liver patients treatment.

SU-E-J-28: Comparison of IGRT Shift Data Between Prostate Gland and Prostate Bed Obtained from Ct-On-Rails

PURPOSE

The daily shifts of prostate gland have been intensively reported in literatures. However, few papers reported daily shifts of prostate bed due to several practical difficulties (e.g. limited soft tissue contrast in MVCT and CBCT and significant deformation of prostate cavity). We have routinely performed IGRT for both prostate gland and bed with ct-on-rails, and the superior image quality allows us not only to differentiate both bony anatomy and soft tissue contrast of prostate gland and bed. In this study, we investigated if the shift of prostate bed is signifiant difference from that of prostate gland.

METHODS

we reviewed shift data of 50 prostate gland patients who underwent 43 fractions and 22 patients of prostatectomy underwent 37 fractions. In total 2150 CT scans were reviewed for prostate gland and 814 scans for prostate bed.

RESULTS

Of the reviewed 814 CT images from 22 prostate bed patients, the standard deviation of shift was found to be 5.9 mm in AP direction (ranges from -22.4mm to 22mm), 3.2mm in SI direction (ranges from -14mm to 14mm), and 4.1mm in lateral direction (ranges from -15mm to 22mm). Of the 2150 CT images of prostate gland from 50 patients, the standard deviation of the shift was found to be 5.4 mm in AP direction (-20mm to 18 mm), 5.0mm in SI direction (-26mm to 20mm), and 4.3mm in lateral direction (range from-15 to 30mm). F tests of systematic /random shift distribution in three orthogonal directions between prostate gland and prostate bed were subsequently performed, it was found that the systematic shift in SI direction for prostate bed is smaller than for prostate gland (p=0.003).

CONCLUSIONS

Our result suggests no significant difference existing in shift between prostate bed and gland. Therefore strategies for daily prostate gland motion can be directly applied to prostate bed.

SU-E-J-35: A Model for the Simulation of EPID Measurements in the BeamNRC Monte Carlo Package

PURPOSE

The intent of this study was to create a virtual model of a simple Electronic Portal Image Device (EPID) in the BeamNRC Monte Carlo package which would simulate EPID measurements taken in vivo.

METHODS

A typical accelerator was created in the BeamNRC software using published 6MV spectra from Mohan, et. al. and the basic head design of a Varian accelerator head. The particle fluence at the level of the mylar window was output into a planar 'phase space' file. The output of this accelerator was delivered to a phantom with a 1 mm thick slab of water acting as the detector array using the DosXYZ package. Additionally, the fluence from the same geometry was computed at the level of the virtualEPID (vEPID). The simulations were run for 2×2, 5×5, 10×10, 20×20, and 25×25 field sizes, as well as a simple IMRT field. The results of the open field simulations were then used for the parameterization of a deconvolution kernel using the form described by Renner, et. al.

RESULTS

The simulations were run with sufficient histories to produce a 1% uncertainty in the resulting fluence and dose matrices in the high dose/fluence region of the output. Additional software was created to convert 'phase space' files to fluence in the same grid as the vEPID. A final software package was written to iteratively determine the exponential fitting parameters described in Ritter, et. al. to deconvolve the detector function from the fluence measurements.

CONCLUSIONS

The system will allow one to simulate both EPID measurements, as well as remove the detector function from vEPIDsimulations for further use in fluence studies using BeamNRC. This will allow one to simulate a system for in vivo patient measurements using an EPID to study without the need for time on a medical accelerator, and without contributing additional radiation fatigue to the EPID device.

MO-F-BRA-02: Evaluation of 4D CT to 4D Cone-Beam CT Deformable Image Registration for Lung Cancer Adaptive Radiation Therapy

PURPOSE

To evaluate two deformable image registration (DIR) algorithms for the purpose of contour mapping to support image guided adaptive radiotherapy (IGART) with 4D cone beam CT (4DCBCT).

METHODS

Eleven locally advanced non-small cell lung cancer (NSCLC) patients underwent one planning 4D fan- beam CT (4DFBCT) and seven weekly 4DCBCT scans. Gross tumor volume (GTV) and carina were delineated by a physician in all 4D images. For day to day registration, the end of inspiration 4DFBCT phase was deformably registered to the corresponding phase in each 4DCBCT image. For phase to phase registration, the end of inspiration phase from each 4D image was registered to end of expiration phase. The delineated contours were warped using the resulting transforms and compared to the manual contours through Dice similarity coefficient (DSC), false positive and false negative indices, and, for carina, target registration error (TRE). Two DIR algorithms were tested: 1) small deformation, inverse consistent linear elastic (SICLE) algorithm and 2) Insight Toolkit diffeomorphic demons (DEMONS).

RESULTS

For day to day registrations, the mean DSC was 0.59 ± 0.16 after rigid registration, 0.72 ± 0.13 with SICLE and to 0.66 ± 0.18 with DEMONS. SICLE and DEMONS reduced TRE to 4.1 ± 2.1 mm and 5.8 ± 3.7 mm respectively, from 6.2 ± 3.5 mm; and reduced false positive index to 0.27 and 0.26 respectively from 0.46. Registration with the cone beam as the fixed image resulted in higher DSC than with the fan beam as fixed (p < 0.001). SICLE and DEMONS increased the DSC on average by 10.0% and 8.0% and reduced TRE by 2.8 mm and 2.9 mm respectively for phase to phase DIR.

CONCLUSIONS

DIR achieved more congruent mapping of target structures to delineations than rigid registration alone, although DIR performance varied with algorithm and patient. This work was supported by National Cancer Institute Grant No. P01 CA 116602.

Magnetic resonance imaging for adaptive cobalt tomotherapy: A proposal

Magnetic resonance imaging (MRI) provides excellent soft tissue contrast for oncology applications. We propose to combine a MRI scanner with a helical tomotherapy (HT) system to enable daily target imaging for improved conformal radiation dose delivery to a patient. HT uses an intensity-modulated fan-beam that revolves around a patient, while the patient slowly advances through the plane of rotation, yielding a helical beam trajectory. Since the use of a linear accelerator to produce radiation may be incompatible with the pulsed radiofrequency and the high and pulsed magnetic fields required for MRI, it is proposed that a radioactive Cobalt-60 ((60)Co) source be used instead to provide the radiation. An open low field (0.25 T) MRI system is proposed where the tomotherapy ring gantry is located between two sets of Helmholtz coils that can generate a sufficiently homogenous main magnetic field.It is shown that the two major challenges with the design, namely acceptable radiation dose rate (and therefore treatment duration) and moving parts in strong magnetic field, can be addressed. The high dose rate desired for helical tomotherapy delivery can be achieved using two radiation sources of 220TBq (6000Ci) each on a ring gantry with a source to axis-of-rotation distance of 75 cm. In addition to this, a dual row multi-leaf collimator (MLC) system with 15 mm leaf width at isocentre and relatively large fan beam widths between 15 and 30 mm per row shall be employed. In this configuration, the unit would be well-suited for most pelvic radiotherapy applications where the soft tissue contrast of MRI will be particularly beneficial. Non-magnetic MRI compatible materials must be used for the rotating gantry. Tungsten, which is non-magnetic, can be used for primary collimation of the fan-beam as well as for the MLC, which allows intensity modulated radiation delivery. We propose to employ a low magnetic Cobalt compound, sycoporite (CoS) for the Cobalt source material itself.Rotational delivery is less susceptible to problems related to the use of a low energy megavoltage photon source while the helical delivery reduces the negative impact of the relatively large penumbra inherent in the use of Cobalt sources for radiotherapy. On the other hand, the use of a (60)Co source ensures constant dose rate with gantry rotation and makes dose calculation in a magnetic field as easy as the range of secondary electrons is limited.The MR-integrated Cobalt tomotherapy unit, dubbed 'MiCoTo,' uses two independent physical principles for image acquisition and treatment delivery. It would offer excellent target definition and will allow following target motion during treatment using fast imaging techniques thus providing the best possible input for adaptive radiotherapy. As an additional bonus, quality assurance of the radiation delivery can be performed in situ using radiation sensitive gels imaged by MRI.

Sci-Thurs PM: Delivery-11: Image guidance for prostate IMRT using low dose cone beam CT

Linac-mounted cone beam computed tomography (CBCT) using Varian's On Board Imager (OBI) currently delivers significant imaging dose and lacks automatic methods for clinical target volume (CTV) registration. In this work, we address these two issues to enable frequent treatment corrections during a course of prostate intensity modulated radiation therapy (IMRT). The process starts by acquiring a low dose (low mAs) CBCT image after patient setup. The image is then used in one of two automatic image guidance strategies. The "global" technique provides the couch corrections necessary to improve patient setup by registering the CBCT to the planning CT. The "local" method involves non-rigid registration of the planning CT to the CBCT followed by automatic treatment re-optimization using the deformed planning CT and contours. Thus, the global method attempts to correct patient setup to match the planned treatment, while the local method corrects the treatment to match the patient setup. Both techniques were evaluated using images of an anthropomorphic male pelvis phantom. Global image guidance resulted in a registration error of 3.6 ± 1.3 mm (imaging dose independent) and high treatment doses to the bladder and rectum for large magnitude motion. The local technique always resulted in clinically acceptable treatment doses due to a reduced registration error of 2.3 ± 0.8 mm, obtained at 15% of the OBI's default dose (125 kVp, 2 mAs per projection). These preliminary results show that our automatic local image guidance technique reduces imaging dose and is sufficiently accurate and robust for application in prostate IMRT.